For: | Gnewuch C, Liebisch G, Langmann T, Dieplinger B, Mueller T, Haltmayer M, Dieplinger H, Zahn A, Stremmel W, Rogler G, Schmitz G. Serum bile acid profiling reflects enterohepatic detoxification state and intestinal barrier function in inflammatory bowel disease. World J Gastroenterol 2009; 15(25): 3134-3141 [PMID: 19575493 DOI: 10.3748/wjg.15.3134] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v15/i25/3134.htm |
Number | Citing Articles |
1 |
Jörg Jahnel, Peter Fickert, Almuthe C. Hauer, Christoph Högenauer, Alexander Avian, Michael Trauner. Inflammatory Bowel Disease Alters Intestinal Bile Acid Transporter Expression. Drug Metabolism and Disposition 2014; 42(9): 1423 doi: 10.1124/dmd.114.058065
|
2 |
P. Pavlidis, N. Powell, R. P. Vincent, D. Ehrlich, I. Bjarnason, B. Hayee. Systematic review: bile acids and intestinal inflammation‐luminal aggressors or regulators of mucosal defence?. Alimentary Pharmacology & Therapeutics 2015; 42(7): 802 doi: 10.1111/apt.13333
|
3 |
Stefanie Sommersberger, Stefan Gunawan, Tanja Elger, Tanja Fererberger, Johanna Loibl, Muriel Huss, Arne Kandulski, Sabrina Krautbauer, Martina Müller, Gerhard Liebisch, Christa Buechler, Hauke Christian Tews. Altered fecal bile acid composition in active ulcerative colitis. Lipids in Health and Disease 2023; 22(1) doi: 10.1186/s12944-023-01971-4
|
4 |
Marc Girardin, Antoine Hadengue, Jean-Louis Frossard, the Swiss IBD Cohort Study Group. High prevalence of cholestasis, with increased conjugated bile acids in inflammatory bowel diseases patients. World Journal of Clinical Cases 2018; 6(4): 44-53 doi: 10.12998/wjcc.v6.i4.44
|
5 |
Wataru Aoi, Teruhide Koyama, Akira Honda, Tomohisa Takagi, Yuji Naito. Association of Serum Bile Acid Profile with Diet and Physical Activity Habits in Japanese Middle-Aged Men. Nutrients 2024; 16(19): 3381 doi: 10.3390/nu16193381
|
6 |
Magdalena Panek-Jeziorna, Agata Mulak. An Inverse Correlation of Serum Fibroblast Growth Factor 19 with Abdominal Pain and Inflammatory Markers in Patients with Ulcerative Colitis. Gastroenterology Research and Practice 2020; 2020: 1 doi: 10.1155/2020/2389312
|
7 |
Qiaoling Yang, Fan Yang, Xiaowen Tang, Lili Ding, Ying Xu, Yinhua Xiong, Zhengtao Wang, Li Yang. Chlorpromazine-induced perturbations of bile acids and free fatty acids in cholestatic liver injury prevented by the Chinese herbal compound Yin-Chen-Hao-Tang. BMC Complementary and Alternative Medicine 2015; 15(1) doi: 10.1186/s12906-015-0627-2
|
8 |
Kathleen Lo, Patil Kavarian, Beibei Wang, Riddhi Parsana, Ramon Durazo-Arvizu, Fengzhu Sun, Sonia Michail. Fecal bile acid profiles before and after fecal microbial transplant in pediatric onset ulcerative colitis. Gut Microbes Reports 2024; 1(1): 1 doi: 10.1080/29933935.2024.2393219
|
9 |
Yong-li Hua, Ya-qian Jia, Xiao-song Zhang, Zi-wen Yuan, Peng Ji, Jun-jie Hu, Yan-ming Wei. Baitouweng Tang ameliorates DSS-induced ulcerative colitis through the regulation of the gut microbiota and bile acids via pathways involving FXR and TGR5. Biomedicine & Pharmacotherapy 2021; 137: 111320 doi: 10.1016/j.biopha.2021.111320
|
10 |
Zhenguo Wang, Chen Xing, Luc J. W. van der Laan, Monique M. A. Verstegen, Bart Spee, Rosalinde Masereeuw. Cholangiocyte organoids to study drug-induced injury. Stem Cell Research & Therapy 2024; 15(1) doi: 10.1186/s13287-024-03692-6
|
11 |
Giulia Roda, Emanuele Porru, Konstantinos Katsanos, Alexandros Skamnelos, Kallirroi Kyriakidi, Gionata Fiorino, Dimitrios Christodoulou, Silvio Danese, Aldo Roda. Serum Bile Acids Profiling in Inflammatory Bowel Disease Patients Treated with Anti-TNFs. Cells 2019; 8(8): 817 doi: 10.3390/cells8080817
|
12 |
Yueyue Ma, Haoze Yang, Xiaoming Wang, Yuhong Huang, Yuhong Li, Guixiang Pan. Bile acids as signaling molecules in inflammatory bowel disease: Implications for treatment strategies. Journal of Ethnopharmacology 2025; 337: 118968 doi: 10.1016/j.jep.2024.118968
|
13 |
Jiahui Zheng, Huan Li, Pei Zhang, Shijun Yue, Bingtao Zhai, Junbo Zou, Jiangxue Cheng, Chongbo Zhao, Dongyan Guo, Jing Wang. Paeonol Ameliorates Ulcerative Colitis in Mice by Modulating the Gut Microbiota and Metabolites. Metabolites 2022; 12(10): 956 doi: 10.3390/metabo12100956
|
14 |
Anna-Kathrin Schupp, Mirko Trilling, Stephanie Rattay, Vu Thuy Khanh Le-Trilling, Katrin Haselow, Jan Stindt, Albert Zimmermann, Dieter Häussinger, Hartmut Hengel, Dirk Graf, R. M. Sandri-Goldin. Bile Acids Act as Soluble Host Restriction Factors Limiting Cytomegalovirus Replication in Hepatocytes. Journal of Virology 2016; 90(15): 6686 doi: 10.1128/JVI.00299-16
|
15 |
Sai Praneeth R. Bathena, Sandeep Mukherjee, Marco Olivera, Yazen Alnouti. The profile of bile acids and their sulfate metabolites in human urine and serum. Journal of Chromatography B 2013; : 53 doi: 10.1016/j.jchromb.2013.10.019
|
16 |
Sandra von Hardenberg, Carsten Gnewuch, Gerd Schmitz, Jürgen Borlak. ApoE is a major determinant of hepatic bile acid homeostasis in mice. The Journal of Nutritional Biochemistry 2018; 52: 82 doi: 10.1016/j.jnutbio.2017.09.008
|
17 |
Xian Cheng, Jian-Liang Zhou, Zi-Qi Shi, Ying-Hao Yin, Jian-Qun Liu, Han-Xiang Chen, Ping Li, Li-Fang Liu, Gui-Zhong Xin. Ammonium fluoride-induced stabilization for anion attachment mass spectrometry: Facilitating the pseudotargeted profiling of bile acids submetabolome. Analytica Chimica Acta 2019; 1081: 120 doi: 10.1016/j.aca.2019.07.006
|
18 |
Mette Klitgaard, Maja Nørgaard Kristensen, Ramakrishnan Venkatasubramanian, Priscila Guerra, Jette Jacobsen, Ragna Berthelsen, Thomas Rades, Anette Müllertz. Assessing acute colitis induced by dextran sulfate sodium in rats and its impact on gastrointestinal fluids. Drug Delivery and Translational Research 2023; 13(5): 1484 doi: 10.1007/s13346-023-01313-y
|
19 |
James C. Poland, C. Robb Flynn. Bile Acids, Their Receptors, and the Gut Microbiota. Physiology 2021; 36(4): 235 doi: 10.1152/physiol.00028.2020
|
20 |
Xu Wang, Dong-ni Cui, Xiao-min Dai, Jing Wang, Wei Zhang, Zun-jian Zhang, Feng-guo Xu. HuangQin Decoction Attenuates CPT-11-Induced Gastrointestinal Toxicity by Regulating Bile Acids Metabolism Homeostasis. Frontiers in Pharmacology 2017; 8 doi: 10.3389/fphar.2017.00156
|
21 |
Libor Vítek. Bile Acid Malabsorption in Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2015; 21(2): 476 doi: 10.1097/MIB.0000000000000193
|
22 |
Zijian Zhou, Dexiang Feng, Donghui Shi, Peng Gao, Lujia Wang, Zhong Wu. Untargeted and targeted metabolomics reveal bile acid profile changes in rats with ethylene glycol-induced calcium oxalate nephrolithiasis. Chemico-Biological Interactions 2023; 381: 110570 doi: 10.1016/j.cbi.2023.110570
|
23 |
Lidiya V. Boldyreva, Anna A. Evtushenko, Maria N. Lvova, Ksenia N. Morozova, Elena V. Kiseleva. Underneath the Gut–Brain Axis in IBD—Evidence of the Non-Obvious. International Journal of Molecular Sciences 2024; 25(22): 12125 doi: 10.3390/ijms252212125
|
24 |
Ai-jin Xie, Chu-tian Mai, Yi-Zhun Zhu, Xian-Cheng Liu, Ying Xie. Bile acids as regulatory molecules and potential targets in metabolic diseases. Life Sciences 2021; 287: 120152 doi: 10.1016/j.lfs.2021.120152
|
25 |
Chi-Hsuan Sung, Rachel Pilla, Sina Marsilio, Betty Chow, Kailee A. Zornow, Jennifer E. Slovak, Jonathan A. Lidbury, Joerg M. Steiner, Steve L. Hill, Jan S. Suchodolski. Fecal Concentrations of Long-Chain Fatty Acids, Sterols, and Unconjugated Bile Acids in Cats with Chronic Enteropathy. Animals 2023; 13(17): 2753 doi: 10.3390/ani13172753
|
26 |
Ali Kiasat, Stefanie Prast-Nielsen, Susanne Rautiainen, Lars Engstrand, Fredrik Andersson, Johan Lindberg, Ina Schuppe-Koistinen, Anna Löf Granström, Ulf O. Gustafsson. Plasma bile acids in association with Crohn’s disease. Scandinavian Journal of Gastroenterology 2024; 59(6): 674 doi: 10.1080/00365521.2024.2328592
|
27 |
Agostino Di Ciaula, Leonilde Bonfrate, Mohamad Khalil, Piero Portincasa. The interaction of bile acids and gut inflammation influences the pathogenesis of inflammatory bowel disease. Internal and Emergency Medicine 2023; 18(8): 2181 doi: 10.1007/s11739-023-03343-3
|
28 |
Frida Fart, Samira Salihović, Aidan McGlinchey, Melanie G. Gareau, Matej Orešič, Jonas Halfvarson, Tuulia Hyötyläinen, Ida Schoultz. Perfluoroalkyl substances are increased in patients with late-onset ulcerative colitis and induce intestinal barrier defectsex vivoin murine intestinal tissue. Scandinavian Journal of Gastroenterology 2021; 56(11): 1286 doi: 10.1080/00365521.2021.1961306
|
29 |
Su Guan, Bingjie Jia, Kang Chao, Xia Zhu, Jian Tang, Miao Li, Lvying Wu, Lei Xing, Kun Liu, Lei Zhang, Xueding Wang, Xiang Gao, Min Huang. UPLC–QTOF-MS-Based Plasma Lipidomic Profiling Reveals Biomarkers for Inflammatory Bowel Disease Diagnosis. Journal of Proteome Research 2020; 19(2): 600 doi: 10.1021/acs.jproteome.9b00440
|
30 |
Jonas J. Staudacher, Cemal Yazici, Timothy Carroll, Jessica Bauer, Jingbo Pang, Nancy Krett, Yinglin Xia, Annette Wilson, Georgios Papachristou, Andrea Dirmeier, Claudia Kunst, David C. Whitcomb, Giamila Fantuzzi, Barbara Jung. Activin in acute pancreatitis: Potential risk-stratifying marker and novel therapeutic target. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-13000-3
|
31 |
Umang Jain, Chin-Wen Lai, Shanshan Xiong, Victoria M. Goodwin, Qiuhe Lu, Brian D. Muegge, George P. Christophi, Kelli L. VanDussen, Bethany P. Cummings, Erick Young, John Hambor, Thaddeus S. Stappenbeck. Temporal Regulation of the Bacterial Metabolite Deoxycholate during Colonic Repair Is Critical for Crypt Regeneration. Cell Host & Microbe 2018; 24(3): 353 doi: 10.1016/j.chom.2018.07.019
|
32 |
Neel Deferm, Lysiane Richert, Pieter Van Brantegem, Tom De Vocht, Bing Qi, Peter de Witte, Thomas Bouillon, Pieter Annaert. Experimental Cholestasis Research. Methods in Molecular Biology 2019; 1981: 335 doi: 10.1007/978-1-4939-9420-5_22
|
33 |
Li Jiao, Hongying Gan-Schreier, Sabine Tuma-Kellner, Wolfgang Stremmel, Walee Chamulitrat. Sensitization to autoimmune hepatitis in group VIA calcium-independent phospholipase A2-null mice led to duodenal villous atrophy with apoptosis, goblet cell hyperplasia and leaked bile acids. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2015; 1852(8): 1646 doi: 10.1016/j.bbadis.2015.04.025
|
34 |
Tingting Yang, Lin Li, Jiale Pang, Cai Heng, Chujing Wei, Xue Wang, Ziyin Xia, Xin Huang, Luyong Zhang, Zhenzhou Jiang. Modulating intestinal barrier function by sphingosine-1-phosphate receptor 1 specific agonist SEW2871 attenuated ANIT-induced cholestatic hepatitis via the gut-liver axis. International Immunopharmacology 2023; 125: 111150 doi: 10.1016/j.intimp.2023.111150
|
35 |
Sagnik Chatterjee, Lysiane Richert, Patrick Augustijns, Pieter Annaert. Hepatocyte-based in vitro model for assessment of drug-induced cholestasis. Toxicology and Applied Pharmacology 2014; 274(1): 124 doi: 10.1016/j.taap.2013.10.032
|
36 |
Xueyun Zheng, Francesca B. Smith, Noor A. Aly, Jingwei Cai, Richard D. Smith, Andrew D. Patterson, Erin S. Baker. Evaluating the structural complexity of isomeric bile acids with ion mobility spectrometry. Analytical and Bioanalytical Chemistry 2019; 411(19): 4673 doi: 10.1007/s00216-019-01869-0
|
37 |
Huiyong Wang, Chu-Yin Yeh, Ke Li, Yu-Wen Chung-Davidson, Weiming Li. An UPLC–MS/MS method for quantitative profiling of bile acids in sea lamprey plasma and tissues. Journal of Chromatography B 2015; 980: 72 doi: 10.1016/j.jchromb.2014.12.018
|
38 |
Aze Wilson, Ahmed Almousa, Wendy A. Teft, Richard B. Kim. Attenuation of bile acid-mediated FXR and PXR activation in patients with Crohn’s disease. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-58644-w
|
39 |
Fanzhi Kong, Xiaoyu Niu, Mingde Liu, Qiuhong Wang. Bile acids LCA and CDCA inhibited porcine deltacoronavirus replication in vitro. Veterinary Microbiology 2021; 257: 109097 doi: 10.1016/j.vetmic.2021.109097
|
40 |
Lauren Adams, Xiang Li, Richard Burchmore, Richard J. A. Goodwin, Daniel M. Wall. Microbiome-derived metabolite effects on intestinal barrier integrity and immune cell response to infection.
Microbiology
2024; 170(10) doi: 10.1099/mic.0.001504
|
41 |
J Trottier, P Caron, R J Straka, O Barbier. Profile of Serum Bile Acids in Noncholestatic Volunteers: Gender-Related Differences in Response to Fenofibrate. Clinical Pharmacology & Therapeutics 2011; 90(2): 279 doi: 10.1038/clpt.2011.124
|
42 |
Jocelyn Trottier, Andrzej Białek, Patrick Caron, Robert J. Straka, Jenny Heathcote, Piotr Milkiewicz, Olivier Barbier. Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: A pilot study. Digestive and Liver Disease 2012; 44(4): 303 doi: 10.1016/j.dld.2011.10.025
|
43 |
Nathan Calzadilla, Shane M. Comiskey, Pradeep K. Dudeja, Seema Saksena, Ravinder K. Gill, Waddah A. Alrefai. Bile acids as inflammatory mediators and modulators of intestinal permeability. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1021924
|
44 |
Rongrong Wu, Rui Xiong, Yan Li, Junru Chen, Ru Yan. Gut microbiome, metabolome, host immunity associated with inflammatory bowel disease and intervention of fecal microbiota transplantation. Journal of Autoimmunity 2023; 141: 103062 doi: 10.1016/j.jaut.2023.103062
|
45 |
Philip G. Hewitt, Prafull Kumar Singh, Arun Kumar, Carsten Gnewuch, Gerhard Liebisch, Gerd Schmitz, Juergen Borlak. A rat toxicogenomics study with the calcium sensitizer EMD82571 reveals a pleiotropic cause of teratogenicity. Reproductive Toxicology 2014; 47: 89 doi: 10.1016/j.reprotox.2014.06.006
|
46 |
Marlies Oorts, Lysiane Richert, Pieter Annaert. Drug-induced cholestasis detection in cryopreserved rat hepatocytes in sandwich culture. Journal of Pharmacological and Toxicological Methods 2015; 73: 63 doi: 10.1016/j.vascn.2015.03.002
|
47 |
Xiaojun Zhang, Franky F. K. Choi, Yan Zhou, Feung P. Leung, Shun Tan, Shuhai Lin, Hongxi Xu, Wei Jia, Joseph J. Y. Sung, Zongwei Cai, Zhaoxiang Bian. Metabolite profiling of plasma and urine from rats with TNBS‐induced acute colitis using UPLC‐ESI‐QTOF‐MS‐based metabonomics – a pilot study. The FEBS Journal 2012; 279(13): 2322 doi: 10.1111/j.1742-4658.2012.08612.x
|
48 |
Ting Jiang, Zidan Yang, Yuqing Zhang, Weiya Zhang, Michael Doherty, Hui Li, Tuo Yang, Yuanheng Yang, Jiatian Li, Yuqing Wang, Chao Zeng, Guanghua Lei, Jie Wei. Dysbiosis of gut microbiota, a potential mediator of bile acid compositions, and prevalence of hand synovitis: a community-based study. Rheumatology 2023; 62(9): 3179 doi: 10.1093/rheumatology/kead042
|
49 |
Marlies Oorts, Audrey Baze, Philippe Bachellier, Bruno Heyd, Thomas Zacharias, Pieter Annaert, Lysiane Richert. Drug-induced cholestasis risk assessment in sandwich-cultured human hepatocytes. Toxicology in Vitro 2016; 34: 179 doi: 10.1016/j.tiv.2016.03.008
|
50 |
Teresa Płatek, Evelyn Orso, Barbara Zapała, Anna Polus, Beata Kieć-Wilk, Monika Piwowar, Monika Chojnacka, Urszula Ciałowicz, Małgorzata Malczewska-Malec, Gerd Schmitz, Bogdan Solnica, Aldona Dembińska-Kieć. Case report of dysregulation of primary bile acid synthesis in a family with X-linked adrenoleukodystrophy. Medicine 2018; 97(49): e13353 doi: 10.1097/MD.0000000000013353
|
51 |
Zhou Wang, Yue Yu, Junyi Liao, Wei Hu, Xiqing Bian, Jianlin Wu, Yi Zhun Zhu. S-Propargyl-Cysteine Remodels the Gut Microbiota to Alleviate Rheumatoid Arthritis by Regulating Bile Acid Metabolism. Frontiers in Cellular and Infection Microbiology 2021; 11 doi: 10.3389/fcimb.2021.670593
|
52 |
Hui Zhang, Xiao Cui, Wei Liu, Zheng Xiang, Ji-Feng Ye. Regulation of intestinal microflora and metabolites of Penthorum chinense Pursh on alcoholic liver disease. Frontiers in Pharmacology 2024; 14 doi: 10.3389/fphar.2023.1331956
|
53 |
Francois-Pierre Martin, Ming-Ming Su, Guo-Xiang Xie, Seu Ping Guiraud, Martin Kussmann, Jean-Philippe Godin, Wei Jia, Andreas Nydegger. Urinary metabolic insights into host-gut microbial interactions in healthy and IBD children. World Journal of Gastroenterology 2017; 23(20): 3643-3654 doi: 10.3748/wjg.v23.i20.3643
|
54 |
Elizabeth A. Scoville, Margaret M. Allaman, Caroline T. Brown, Amy K. Motley, Sara N. Horst, Christopher S. Williams, Tatsuki Koyama, Zhiguo Zhao, Dawn W. Adams, Dawn B. Beaulieu, David A. Schwartz, Keith T. Wilson, Lori A. Coburn. Alterations in lipid, amino acid, and energy metabolism distinguish Crohn’s disease from ulcerative colitis and control subjects by serum metabolomic profiling. Metabolomics 2018; 14(1) doi: 10.1007/s11306-017-1311-y
|
55 |
Pieter Van Brantegem, Sagnik Chatterjee, Tom De Bruyn, Pieter Annaert, Neel Deferm. Drug-induced cholestasis assay in primary hepatocytes. MethodsX 2020; 7: 101080 doi: 10.1016/j.mex.2020.101080
|
56 |
Benedikt Hild, Hauke S. Heinzow, Hartmut H. Schmidt, Miriam Maschmeier. Bile Acids in Control of the Gut-Liver-Axis. Zeitschrift für Gastroenterologie 2021; 59(01): 63 doi: 10.1055/a-1330-9644
|
57 |
Meiling Liu, Siyi Guo, Liang Wang. Systematic review of metabolomic alterations in ulcerative colitis: unveiling key metabolic signatures and pathways. Therapeutic Advances in Gastroenterology 2024; 17 doi: 10.1177/17562848241239580
|
58 |
Jinke Huang, Jiaqi Zhang, Fengyun Wang, Xudong Tang. Modified Gegen Qinlian Decoction modulated the gut microbiome and bile acid metabolism and restored the function of goblet cells in a mouse model of ulcerative colitis. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1445838
|
59 |
Věra Dosedělová, Petra Itterheimová, Petr Kubáň. Analysis of bile acids in human biological samples by microcolumn separation techniques: A review. ELECTROPHORESIS 2021; 42(1-2): 68 doi: 10.1002/elps.202000139
|
60 |
Christopher Staley, Alexa R. Weingarden, Alexander Khoruts, Michael J. Sadowsky. Interaction of gut microbiota with bile acid metabolism and its influence on disease states. Applied Microbiology and Biotechnology 2017; 101(1): 47 doi: 10.1007/s00253-016-8006-6
|
61 |
Xueyan Zhou, Lijuan Cao, Changtao Jiang, Yang Xie, Xuefang Cheng, Kristopher W. Krausz, Yunpeng Qi, Lu Sun, Yatrik M. Shah, Frank J. Gonzalez, Guangji Wang, Haiping Hao. PPARα-UGT axis activation represses intestinal FXR-FGF15 feedback signalling and exacerbates experimental colitis. Nature Communications 2014; 5(1) doi: 10.1038/ncomms5573
|
62 |
Petar D. Petrov, Leonor Fernández-Murga, Isabel Conde, Teresa Martínez-Sena, Carla Guzmán, José Vicente Castell, Ramiro Jover. Epistane, an anabolic steroid used for recreational purposes, causes cholestasis with elevated levels of cholic acid conjugates, by upregulating bile acid synthesis (CYP8B1) and cross-talking with nuclear receptors in human hepatocytes. Archives of Toxicology 2020; 94(2): 589 doi: 10.1007/s00204-019-02643-y
|
63 |
Petar D. Petrov, Polina Soluyanova, Sonia Sánchez-Campos, José V. Castell, Ramiro Jover. Molecular mechanisms of hepatotoxic cholestasis by clavulanic acid: Role of NRF2 and FXR pathways. Food and Chemical Toxicology 2021; 158: 112664 doi: 10.1016/j.fct.2021.112664
|
64 |
Thomas Clavel, Patricia Lepage, Cédric Charrier. The Prokaryotes. 2014; : 201 doi: 10.1007/978-3-642-30138-4_343
|
65 |
Marlies Oorts, Pieter Van Brantegem, Neel Deferm, Sagnik Chatterjee, Erwin Dreesen, Axelle Cooreman, Mathieu Vinken, Lysiane Richert, Pieter Annaert. Bosentan Alters Endo- and Exogenous Bile Salt Disposition in Sandwich-Cultured Human Hepatocytes. Journal of Pharmacology and Experimental Therapeutics 2021; 379(1): 20 doi: 10.1124/jpet.121.000695
|
66 |
Meihua Liu, Zhonghua Wang, Xuan Liu, Hang Xiao, Yangcheng Liu, Jiaqi Wang, Changlan Chen, Xin Wang, Wei Liu, Zheng Xiang, Dongmei Yue. Therapeutic effect of Yiyi Fuzi Baijiang formula on TNBS-induced ulcerative colitis via metabolism and Th17/Treg cell balance. Journal of Ethnopharmacology 2023; 309: 116301 doi: 10.1016/j.jep.2023.116301
|
67 |
Xueheng Zhao, Kenneth DR Setchell, Rong Huang, Indika Mallawaarachchi, Lubaina Ehsan, Edward Dobrzykowski III, Junfang Zhao, Sana Syed, Jennie Z Ma, Najeeha T Iqbal, Junaid Iqbal, Kamran Sadiq, Sheraz Ahmed, Yael Haberman, Lee A Denson, Syed Asad Ali, Sean R Moore. Bile Acid Profiling Reveals Distinct Signatures in Undernourished Children with Environmental Enteric Dysfunction. The Journal of Nutrition 2021; 151(12): 3689 doi: 10.1093/jn/nxab321
|